HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

• 收藏
• 分享

专利权人:

Alnylam Pharmaceuticals; Inc.

发明人:

Gregory Hinkle,Laura Sepp-Lorenzino,Vasant Jadhav,Martin Maier,Muthiah Manoharan,Stuart Milstein,Svetlana Shulga Morskaya,Kallanthottathil G. Rajeev,Huilei Xu

申请号：

US15591558

公开号：

US20170349901A1

申请日:

2017.05.10

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The present invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the hepatitis D virus (HDV) genome, and methods of using such RNAi agents to inhibit expression of one or more HBV genes and methods of treating subjects having an HDV infection and/or HDV-associated disorder.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/